Understanding Mycetoma: A Guide to the Basics
At a Glance
Mycetoma is a slow-growing, noncontagious infection caused by fungi or bacteria that enter through skin injuries. Identifying the type early is essential because fungal and bacterial forms need different treatments, and untreated infection can reach bone and impair movement.
Mycetoma is a chronic, progressive infection that primarily affects the skin, the tissue just under the skin (subcutaneous tissue), and eventually the underlying bone [1][2]. It is often misunderstood because it grows slowly and typically does not cause significant pain in its early stages [1]. However, it is not a cancer; it is an infection caused by either fungi or bacteria [3]. Mycetoma is not contagious and cannot be passed from person to person.
Because it develops over months or years, many people delay seeking medical care. This delay can lead to serious consequences, including permanent deformity, loss of function in the affected limb, or the need for amputation [4][5].
Two Distinct Forms: Fungal vs. Bacterial
Although they may look similar on the outside, mycetoma is divided into two very different types based on the organism causing the infection. Distinguishing between them is the most important step in your care because the treatments are entirely different [3][6].
- Eumycetoma (Fungal): Caused by filamentous fungi (molds), most commonly Madurella mycetomatis [3]. This form is often harder to treat and usually requires a combination of long-term antifungal medication and surgery [1][6].
- Actinomycetoma (Bacterial): Caused by filamentous bacteria, such as species of Nocardia or Streptomyces [3]. This form generally responds well to specific long-term antibiotics and rarely requires surgery [6].
One of the hallmark signs of mycetoma is the presence of grains—small, seed-like particles found in the fluid draining from the infection site [1]. The color of these grains can provide a clue to the cause: eumycetoma often produces black grains, while actinomycetoma typically produces white, yellow, or red grains [7]. However, grain color alone is not enough for a final diagnosis; laboratory testing is essential [8].
How Mycetoma is Acquired
Mycetoma is an environmental infection. The organisms that cause it live in the soil and on plants, particularly in dry, tropical, and subtropical regions known as the Mycetoma Belt [9][10]. This includes parts of Sudan, India, Mexico, and several countries in Africa and the Arabian Peninsula [9].
The infection usually enters the body through traumatic inoculation—a minor injury that breaks the skin and allows contaminated soil or plant material to enter [11]. Common paths of transmission include:
- Thorn pricks: Sharp thorns from acacia trees or other desert plants can push the fungi or bacteria deep into the tissue [11][12].
- Walking barefoot: Tiny cuts or abrasions on the feet from soil, stones, or gravel allow the organisms to enter [13][14].
- Occupational exposure: Farmers, herders, and outdoor laborers are at higher risk because of frequent contact with soil and livestock [15][14].
How the Infection Spreads Locally
Once the organism is “planted” under the skin, it does not stay in one spot. It creates a granuloma, which is a focused area of intense inflammation where the body’s immune system tries to wall off the invader [16].
The infection spreads through the tissue in a predictable but destructive way:
- Subcutaneous Growth: It starts as a firm, painless lump under the skin [1][2].
- Sinus Tracts: As the infection grows, it creates tunnels called sinus tracts that lead from the deep tissue to the surface of the skin [1]. These tracts periodically drain fluid containing grains [1].
- Deep Tissue Invasion: Over time, the infection crosses “tissue planes” (the layers of fat and muscle), invading deeper structures like tendons and nerves [17][18].
- Bone Involvement: In advanced stages, the infection may spread to the bone, causing osteomyelitis (bone infection) and creating “punched-out” holes or lesions in the bone structure [17][18].
The Importance of Early Action
Because mycetoma progresses slowly, it is easy to ignore in the beginning. However, waiting allows the infection to spread into the bone, which makes medical treatment much less effective [4][5].
Advanced disease often leads to significant disability, affecting your ability to walk or work [19]. In severe or uncontrolled cases, the damage to the bone and surrounding tissue may become so extensive that the only way to stop the infection from spreading further is through amputation [9][20]. Seeking a specialized diagnosis as soon as you notice a persistent lump or draining sore is the best way to protect your health and mobility.
Common questions in this guide
What is mycetoma, and is it cancer or contagious?
How are fungal and bacterial mycetoma different?
How does someone develop mycetoma?
What do the grains in mycetoma drainage mean?
Can mycetoma spread to the bone?
What tests are used to diagnose mycetoma?
When should I seek medical care for a possible mycetoma?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Mycetoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Have you identified whether my infection is eumycetoma (fungal) or actinomycetoma (bacterial), and which specific organism is causing it?
- 2.What tests—such as microscopy, culture, or PCR—were used to confirm the diagnosis?
- 3.Based on imaging like an MRI or CT scan, how deep has the infection spread into my muscle or bone?
- 4.How long do you expect my treatment to last, and what are the most common side effects of the medications I will be taking?
- 5.If surgery is needed, will it be a minor procedure to remove a small area, or is a larger surgery required to protect the rest of my limb?
- 6.What is the risk of the infection returning after treatment, and what kind of long-term follow-up will I need?
References
References (20)
- 1
Mycetoma: reviewing a neglected disease.
Verma P, Jha A
Clinical and experimental dermatology 2019; (44(2)):123-129 doi:10.1111/ced.13642.
PMID: 29808607 - 2
Mycetoma: The Spectrum of Clinical Presentation.
Fahal AH, Suliman SH, Hay R
Tropical medicine and infectious disease 2018; (3(3)) doi:10.3390/tropicalmed3030097.
PMID: 30274493 - 3
An updated list of eumycetoma causative agents and their differences in grain formation and treatment response.
van de Sande WWJ, Fahal AH
Clinical microbiology reviews 2024; (37(2)):e0003423 doi:10.1128/cmr.00034-23.
PMID: 38690871 - 4
Madura's foot: reasons for the delay in diagnosis and consequences for the management (a case report).
Boanimbek B, Aznague Y, Abass GO, et al.
The Pan African medical journal 2020; (37()):75 doi:10.11604/pamj.2020.37.75.24983.
PMID: 33244338 - 5
Advanced Eumycetoma of the Right Foot Resulting in Below-Knee Amputation in Somalia: A Case Report.
Mahamud MA, Ahmed MM, Hassan SA, et al.
International medical case reports journal 2026; (19()):633948 doi:10.2147/IMCRJ.S633948.
PMID: 42808000 - 6
[Mycetoma and their treatment].
Develoux M
Journal de mycologie medicale 2016; (26(2)):77-85 doi:10.1016/j.mycmed.2016.03.005.
PMID: 27260344 - 7
Cervicofacial Actinomycetoma Presenting with Black Grain: A Rare Clinical Scenario.
Lodha S, Biswas S, Basu A, et al.
The Journal of the Association of Physicians of India 2024; (72(8)):83-85 doi:10.59556/japi.72.0531.
PMID: 39163074 - 8
Mycetoma laboratory diagnosis: Review article.
Ahmed AA, van de Sande W, Fahal AH
PLoS neglected tropical diseases 2017; (11(8)):e0005638 doi:10.1371/journal.pntd.0005638.
PMID: 28837657 - 9
Global sociodemographic, clinical, and epidemiological profiling of patients with mycetoma: A systematic review.
Salah ME, Fearon Scales ML, Habib K, et al.
PLoS neglected tropical diseases 2025; (19(8)):e0013217 doi:10.1371/journal.pntd.0013217.
PMID: 40811735 - 10
Estimating the burden of mycetoma in Sudan for the period 1991-2018 using a model-based geostatistical approach.
Hassan R, Cano J, Fronterre C, et al.
PLoS neglected tropical diseases 2022; (16(10)):e0010795 doi:10.1371/journal.pntd.0010795.
PMID: 36240229 - 11
Unravelling the challenges of mycetoma: a case series highlighting diagnostic dilemmas and therapeutic triumphs.
Mathur M, Thakur N, Jaiswal S, et al.
Skin health and disease 2025; (5(1)):61-65 doi:10.1093/skinhd/vzae017.
PMID: 40125017 - 12
Climate, soil type, and geographic distribution of actinomycetoma cases in Northeast Mexico: A cross-sectional study.
Cardenas-de la Garza JA, Welsh O, Cuellar-Barboza A, et al.
PloS one 2020; (15(5)):e0232556 doi:10.1371/journal.pone.0232556.
PMID: 32384126 - 13
Epidemiology, risk factors, and awareness of mycetoma among residents in Eastern Sinnar locality, Sudan, 2021.
Abdallh MGA, Hemeda S, Elmadani M, et al.
Journal of global health 2025; (15()):04005 doi:10.7189/jogh.15.04005.
PMID: 39791422 - 14
Environmental and structural risk factors for mycetoma in the White Nile State, Sudan: an ethnographic study.
Alnoor B, Nahar P, Abu Zied O, Fairhead J
International journal for equity in health 2026; (25(1)):42 doi:10.1186/s12939-026-02768-4.
PMID: 41639682 - 15
Individual Risk Factors of Mycetoma Occurrence in Eastern Sennar Locality, Sennar State, Sudan: A Case-Control Study.
Hassan R, Deribe K, Simpson H, et al.
Tropical medicine and infectious disease 2022; (7(8)) doi:10.3390/tropicalmed7080174.
PMID: 36006266 - 16
A conserved grain-associated immunosuppressive niche in Sudanese patients with mycetoma.
Osman M, Ashwin H, Calder G, et al.
PLoS neglected tropical diseases 2026; (20(8)):e0014230 doi:10.1371/journal.pntd.0014230.
PMID: 42607090 - 17
Mycetoma imaging: the best practice.
Bahar ME, Bakheet OELH, Fahal AH
Transactions of the Royal Society of Tropical Medicine and Hygiene 2021; (115(4)):387-396 doi:10.1093/trstmh/traa178.
PMID: 33537774 - 18
Imaging of Madura foot: Case report.
Rais A, Bouardi NE, Bouanani Z, et al.
Radiology case reports 2024; (19(11)):4747-4750 doi:10.1016/j.radcr.2024.07.042.
PMID: 39228927 - 19
The disabling consequences of Mycetoma.
Abbas M, Scolding PS, Yosif AA, et al.
PLoS neglected tropical diseases 2018; (12(12)):e0007019 doi:10.1371/journal.pntd.0007019.
PMID: 30532253 - 20
Surgical management of eumycetoma: experience from Gezira Mycetoma Center, Sudan.
Gismalla MDA, Ahmed GMA, MohamedAli MM, et al.
Tropical medicine and health 2019; (47()):6 doi:10.1186/s41182-018-0129-2.
PMID: 30675125
This page explains the basics of mycetoma for education and does not replace medical advice. A qualified clinician or specialist should confirm the infection type, depth, and treatment plan for your situation.